Interview with Piotr Kula, Director of Research and Development at Olimp Laboratories Sp. z o.o. Piotr Kula, M.Sc, Eng., Director of Research and Development at Olimp Laboratories He has been working in the company since 2005. Biotechnologist. Author and co-author of many innovative products, investment projects and patents. Involved in strategic plan- ning and new business developments. Coordinates new products develop- ment processes. Head of following departments: R&D Pharma and Medi- cal Device, R&D Sport and Functional Food; Laboratory of Research & De- velopment, Technology and Pharma- ceutical Form Development Depart- ment. -> p.kula@olimp-labs.com In brief Core Competence Innovative dietary supplements and pharmaceuticals Facts & Figures • Founded: 1990 • Structure: Part of Capital Group Olimp-Nutrifarm • Branch offices: Subsidiaries in Poland, Germany, Spain and the United Kingdom, Italy, Belgium, in the USA • Employees: More than 500 • Turnover: 100 million EUR • Export: 40% to more than 90 countries • Investments: over 80 million EUR in R&D and new technolo- gies in the past decade Products & Services • Products: over 300 including more than 1,000 SKUs • Dietary supplements, pharmaceuticals and functional food, veterinary products, R&D and contract manufacture Target Groups Pharmacies and health stores, fitness centers & gyms, B2B, B2C, E-commerce, “omnichannel”, FMCG Fairs & Exhibitions FIBO, Arnold Classic, Mr. Olympia, Body Power, Supply Side West, Health & Food Ingredients and more Philosophy A more comfortable life, strength, health and vitality Future Functional food, pharmaceuticals and personalized supple- mentation for the prevention of social diseases N A E P O R U E business Olimp Laboratories Sp. z o.o. Pustynia 84 F 39-200 Dębica Poland +48 14 680 32 00 +48 14 680 32 65 info@olimp-labs.com www.olimpsport.com, www.olimp-labs.com Not only popular in Poland, Olimp ent. As head of Olimp Lab’s R&D Labs maintains a large interna- department, Mr. Kula is intent on tional presence. “We export our moving the company forward and products to more than 90 coun- already has a lot of ideas about tries. Exports generate 40% of our how to accomplish that. “We are total turnover, and we continue to looking at new areas, especially grow by 10% to 12% each year. in terms of pharmaceuticals and We want to continue our dynamic functional food. One thing that is international expansion, especially really important to us is to do our in North America and Asia,” points share to prevent common social out Mr. Kula. This international diseases like cadiovascular, neu- growth is in no small part due to rodegenerative disease. We would the firm’s excellent marketing, also like to keep working with uni- such as online and at major in- versities, research units and sport dustry trade fairs. Olimp Labs also associations,” shares the director. cooperates with top universities in Poland and abroad as well in its area to help develop local tal- Olimp Labs’ state-of-the-art production facility and interdisciplinary Research & Development Centre with total area of 26,000 m2. Nutrifarm’s Intelligent Logistic Centre with capacity for 23,000 pallets & Euroboxes and approx. 129,000 m³ www.european-business.com 10